The phase 3 trial showed relacorilant with chemotherapy improved progression-free and overall survival in platinum-resistant ...

New phase 3 data provide reassurance on safety, tolerability, and overall benefit-risk of mirvetuximab soravtansine (Elahere) ...

The first patient was dosed in a phase 3 trial of IBI354 for platinum-resistant ovarian cancer with HER2 expression.

Anixa Biosciences Receives Notice of Allowance from USPTO for Ovarian Cancer Vaccine. Anixa Biosciences, Inc. March 24, 2025.

Nemvaleukin alfa with pembrolizumab missed the overall survival primary end point in ARTISTRY-7 for platinum-resistant ...

A comparison of patients with and without BRCA gene mutations receiving prophylactic risk-reduction surgery suggest ...

Toon Van Gorp, MD, PhD, discussed findings from the MIRASOL trial and the potential of mirvetuximab to redefine treatment ...

The University of Pennsylvania has taken a novel approach to ensure that women with suspicious adnexal lesions are referred ...

It does not necessarily reflect the view of The Herald. While you might have heard about ovarian cancer, you might be unsure of the symptoms you should look out for as well as the causes and how ...

A hysterectomy may be combined with an oophorectomy to lower your chances of ovarian cancer if you’re at particularly ... Vertical incisions offer the surgeon a better view, but horizontal ...